Stock Image

The Lock and Key of Medicine: Monoclonal Antibodies and the Transformation of Healthcare

Marks, Lara V.

2 ratings by Goodreads
ISBN 10: 0300167733 / ISBN 13: 9780300167733
Published by Yale University Press
New Condition: New Hardcover
From Kennys Bookstore (Olney, MD, U.S.A.)

AbeBooks Seller Since 09 October 2009

Quantity Available: 3
Buy New
List Price: 40.00
Price: £ 29.97 Convert Currency
Shipping: £ 0 Within U.S.A. Destination, Rates & Speeds
Add to basket

About this Item

The untold story of monoclonal antibodies-the molecular heroes of biotechnology that revolutionized the diagnosis and treatment of more than fifty major diseases Num Pages: 344 pages, 37 b/w illus. BIC Classification: MBP; MBX; MJCM; MMG. Category: (P) Professional & Vocational. Dimension: 245 x 165 x 29. Weight in Grams: 638. . 2015. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Bookseller Inventory # V9780300167733

Ask Seller a Question

Bibliographic Details

Title: The Lock and Key of Medicine: Monoclonal ...

Publisher: Yale University Press

Binding: Hardcover

Book Condition:New

About this title

Synopsis:

The untold story of monoclonal antibodies—the molecular heroes of biotechnology that revolutionized the diagnosis and treatment of more than fifty major diseases

This book is the first to tell the extraordinary yet unheralded history of monoclonal antibodies. Often referred to as Mabs, they are unfamiliar to most nonscientists, yet these microscopic protein molecules are everywhere, quietly shaping our lives and healthcare. Discovered in the mid-1970s in the laboratory where Watson and Crick had earlier unveiled the structure of DNA, Mabs have radically changed understandings of the pathways of disease. They have enabled faster, cheaper, and more accurate clinical diagnostic testing on a vast scale. And they have played a fundamental role in pharmaceutical innovation, leading to such developments as recombinant interferon and insulin, and personalized drug therapies such as Herceptin. Today Mabs constitute six of the world’s top ten blockbuster drugs and make up a third of new introduced treatments.
 
Lara V. Marks recounts the risks and opposition that a daring handful of individuals faced while discovering and developing Mabs, and she addresses the related scientific, medical, technological, business, and social challenges that arose. She offers a saga of entrepreneurs whose persistence and creativity ultimately changed the healthcare landscape and brought untold relief to millions of patients. Even so, as Marks shows, controversies over Mabs remain, and she examines current debates over the costs and effectiveness of these innovative drugs.

About the Author:

Lara V. Marks is a historian of medicine. She is managing editor of the website whatisbiotechnology.org and has research affiliations with King’s College London and Cambridge University. She lives in Kent, UK.

"About this title" may belong to another edition of this title.

Store Description

We carry a comprehensive range of out of print and rare books.

Visit Seller's Storefront

Terms of Sale:

We guarantee the condition of every book as it's described on the Abebooks web
sites. If you're dissatisfied with your purchase (Incorrect Book/Not as
Described/Damaged) or if the order hasn't arrived, you're eligible for a refund
within 30 days of the estimated delivery date. For any queries please use the contact seller link or send an email to books@kennys.ie,

Conor Kenny

Shipping Terms:

All books securely packaged. Some books ship from Ireland.

List this Seller's Books

Payment Methods
accepted by seller

Visa Mastercard American Express